HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

6'-sialyllactose

Networked: 12 relevant articles (2 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Carbohydrates: 22023
- Polysaccharides: 15383
  - Oligosaccharides: 3566
    - Disaccharides: 990
      - Lactose: 2186
        6'-sialyllactose: 12
- Sugars: 11126
  - Disaccharides: 990
    - Lactose: 2186
      - 6'-sialyllactose: 12

Experts

1.	Banfield, Emilyn: 2 articles (01/2021 - 01/2021)
2.	Buck, Rachael H: 2 articles (01/2021 - 01/2021)
3.	Fulton, William B: 2 articles (01/2021 - 01/2021)
4.	Goehring, Karen C: 2 articles (01/2021 - 01/2021)
5.	Hackam, David J: 2 articles (01/2021 - 01/2021)
6.	Jia, Hongpeng: 2 articles (01/2021 - 01/2021)
7.	Kovler, Mark: 2 articles (01/2021 - 01/2021)
8.	Ladd, Mitchell R: 2 articles (01/2021 - 01/2021)
9.	Lu, Peng: 2 articles (01/2021 - 01/2021)
10.	Niño, Diego F: 2 articles (01/2021 - 01/2021)

Related Diseases

1.	Muscular Diseases (Myopathy) 12/01/2023 - "We performed a pilot clinical trial to analyze the pharmacokinetic properties of 6'-sialyllactose (6SL) and evaluated the safety, and efficacy of oral 6SL in patients with GNE myopathy. " 12/01/2023 - "Pharmacokinetics and clinical efficacy of 6'-sialyllactose in patients with GNE myopathy: Randomized pilot trial." 10/01/2014 - "6'-sialyllactose ameliorated muscle atrophy and degeneration in symptomatic GNE myopathy mice. " 10/01/2014 - "Our results provide evidence that GNE myopathy can be treated even at a progressive stage and 6'-sialyllactose has more remarkable advantage than free sialic acid, providing a conceptual proof for clinical use in patients."
2.	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 09/12/2019 - "6'-Sialyllactose Ameliorates In Vivo and In Vitro Benign Prostatic Hyperplasia by Regulating the E2F1/pRb-AR Pathway."
3.	Necrotizing Enterocolitis 01/01/2021 - "Insights image for "The human milk oligosaccharides 2'-fucosyllactose and 6'-sialyllactose protect against the development of necrotizing enterocolitis by inhibiting toll-like receptor 4 signaling."" 01/01/2021 - "The human milk oligosaccharides 2'-fucosyllactose and 6'-sialyllactose protect against the development of necrotizing enterocolitis by inhibiting toll-like receptor 4 signaling."
4.	Influenza in Birds (Avian Flu) 01/01/2020 - "Here, we describe the rapid and efficient synthesis of PAMAM dendrimers conjugated with either 3'-sialyllactose (3SL) or 6'-sialyllactose (6SL) and their potential to inhibit a diverse range of human and avian influenza virus strains. " 01/01/2018 - "Two sialylated human milk oligosaccharides (SHMOs) 3'-sialyllactose (3'-SL) and 6'-sialyllactose (6'-SL) were accessed for their possible antiviral activity against six different subtypes of thirteen avian influenza (AI) viruses in vitro. "
5.	Lung Injury 11/09/2023 - "Human milk oligosaccharides 3'-sialyllactose and 6'-sialyllactose attenuate LPS-induced lung injury by inhibiting STAT1 and NF-κB signaling pathways."

Related Drugs and Biologics

1.	Oligosaccharides
2.	3'-sialyllactose
3.	2'-fucosyllactose
4.	Toll-Like Receptor 4
5.	Antiviral Agents (Antivirals)
6.	Dendrimers (Dendrons)
7.	Chitosan
8.	N-Acetylneuraminic Acid (Sialic Acid)
9.	Photosensitizing Agents (Photosensitizers)
10.	Ovalbumin